Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FV1N8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,457
Award facts
- Contract value 100% obligated
- $11,457.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,457.45 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. This non-set-aside, firm fixed-price contract is scheduled for completion by August 11, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively selected to fulfill this requirement. The company maintains an extensive portfolio of federal pharmaceutical supply contracts with the Defense Logistics Agency and serves military healthcare systems, the Defense Health Agency, and other government healthcare entities. Dupixent is a prescription biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and eosinophilic conditions, making this delivery order part of the broader pharmaceutical supply chain supporting Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FV1N8?
SPE2DB25FV1N8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FV1N8 worth?
The government has obligated $11,457 on SPE2DB25FV1N8.
Is contract SPE2DB25FV1N8 an order under another contract?
Yes. SPE2DB25FV1N8 is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FV1N8 competed?
The extent of competition for SPE2DB25FV1N8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award